Avid Radiopharmaceuticals Email Format

Pharmaceutical ManufacturingPennsylvania, United States51-200 Employees

Avid Radiopharmaceuticals develops molecular imaging agents intended to influence the management of significant chronic diseases by enabling detection of early pathological changes, potentially before symptoms appear. Avid has assembled a leadership team with extensive experience in imaging and CNS development to support efforts toward pre-symptomatic disease detection. The company is a wholly owned subsidiary of Eli Lilly and Company.
Based in Philadelphia, Pennsylvania, it operates in the pharmaceutical manufacturing sector and concentrates on a pipeline of imaging compounds. Its focus includes conditions such as Alzheimer's disease, Dementia with Lewy Bodies, Parkinson's disease, and Diabetes Mellitus, with the aim of detecting the initial stages of pathology to inform early treatment and management.

Sign up for free to view info

Company overview Employee directory